See more : Middlesex Water Company PFD 7% (MSEXP) Income Statement Analysis – Financial Results
Complete financial analysis of Covetrus, Inc. (CVET) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Covetrus, Inc., a leading company in the Medical – Distribution industry within the Healthcare sector.
- High Country Bancorp, Inc. (HCBC) Income Statement Analysis – Financial Results
- Telia Company AB (publ) (TLSNY) Income Statement Analysis – Financial Results
- Asetek A/S (0QDT.L) Income Statement Analysis – Financial Results
- Xinjiang Goldwind Science & Technology Co., Ltd. (002202.SZ) Income Statement Analysis – Financial Results
- Altus Power, Inc. (AMPS-WT) Income Statement Analysis – Financial Results
Covetrus, Inc. (CVET)
About Covetrus, Inc.
Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific. The company was formerly known as HS Spinco, Inc. Covetrus, Inc. was incorporated in 2018 and is headquartered in Portland, Maine. As of October 13, 2022, Covetrus, Inc. was taken private.
Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|
Revenue | 4.58B | 4.34B | 3.98B | 3.78B | 3.58B | 3.35B | 2.98B |
Cost of Revenue | 3.72B | 3.54B | 3.23B | 3.09B | 2.93B | 2.73B | 2.45B |
Gross Profit | 858.00M | 798.00M | 749.00M | 684.11M | 652.03M | 619.91M | 530.02M |
Gross Profit Ratio | 18.75% | 18.39% | 18.84% | 18.11% | 18.21% | 18.49% | 17.80% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 867.00M | 808.00M | 538.47M | 516.70M | 488.82M | 417.87M |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 881.00M | 867.00M | 808.00M | 538.47M | 516.70M | 488.82M | 417.87M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 881.00M | 867.00M | 808.00M | 538.47M | 516.70M | 488.82M | 417.87M |
Cost & Expenses | 4.60B | 4.41B | 4.04B | 3.63B | 3.44B | 3.22B | 2.87B |
Interest Income | 0.00 | 1.00M | 7.00M | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 32.00M | 47.00M | 56.00M | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 200.00M | 190.00M | 176.00M | 64.10M | 59.05M | 55.45M | 50.30M |
EBITDA | 178.00M | 211.00M | -794.00M | 201.99M | 171.43M | 153.68M | 134.89M |
EBITDA Ratio | 3.89% | 4.86% | -19.97% | 5.35% | 4.79% | 4.58% | 4.53% |
Operating Income | -22.00M | -69.00M | -997.00M | 137.10M | 135.32M | 123.83M | 103.81M |
Operating Income Ratio | -0.48% | -1.59% | -25.08% | 3.63% | 3.78% | 3.69% | 3.49% |
Total Other Income/Expenses | -32.00M | 45.00M | -32.00M | 6.08M | 3.45M | 2.97M | 4.69M |
Income Before Tax | -54.00M | -24.00M | -1.03B | 143.18M | 138.77M | 126.79M | 108.50M |
Income Before Tax Ratio | -1.18% | -0.55% | -25.88% | 3.79% | 3.88% | 3.78% | 3.64% |
Income Tax Expense | 32.00M | -7.00M | -7.00M | 37.03M | 48.02M | 27.94M | 24.27M |
Net Income | -86.00M | -19.00M | -1.02B | 100.86M | 64.35M | 70.30M | 60.32M |
Net Income Ratio | -1.88% | -0.44% | -25.63% | 2.67% | 1.80% | 2.10% | 2.03% |
EPS | -0.63 | -0.16 | -9.52 | 0.91 | 0.58 | 0.63 | 0.54 |
EPS Diluted | -0.63 | -0.16 | -9.52 | 0.91 | 0.58 | 0.63 | 0.54 |
Weighted Avg Shares Out | 137.00M | 118.00M | 107.00M | 111.19M | 111.19M | 111.19M | 111.19M |
Weighted Avg Shares Out (Dil) | 137.00M | 118.00M | 107.00M | 111.19M | 111.19M | 111.19M | 111.19M |
Covetrus Announces Third Quarter 2020 Earnings Release Date and Conference Call Information
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q2 2020 Update
Biotech Bonanza - Second Half Outlook
Silver Ring Value Partners Q2 2020 Letter
ClearBridge Small Cap Strategy Portfolio Manager Commentary Q2 2020
Invesco Ltd. Cuts Stock Holdings in Covetrus Inc (NASDAQ:CVET)
FDx Advisors Inc. Acquires New Shares in Covetrus Inc (NASDAQ:CVET)
Covetrus (CVET) – Analysts’ Recent Ratings Updates
Covetrus Inc (NASDAQ:CVET) Shares Purchased by Two Sigma Advisers LP
Source: https://incomestatements.info
Category: Stock Reports